Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy

Pediatric Infectious Disease Journal

Volumn 25, Issue 5, 2006, Pages 427-431

  Hartman, Karin ^a   Verweel, Gwenda ^a   De Groot, Ronald ^b   Hartwig, Nico G ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Children; HAART; HIV; Lipoatrophy; Lipodystrophy

Indexed keywords

ANTIRETROVIRUS AGENT; C PEPTIDE; CHOLESTEROL; DIDANOSINE; EFAVIRENZ; INDINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; VIRUS RNA;

ADOLESCENT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; CD4+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LIPID BLOOD LEVEL; LIPOATROPHY; MALE; PRIORITY JOURNAL; SKINFOLD THICKNESS; TREATMENT OUTCOME; VIRUS LOAD; WAIST HIP RATIO;

ADOLESCENT; ANTHROPOMETRY; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY COMPOSITION; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; INFANT; MALE;

EID: 33646801173     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000215003.32256.aa     Document Type: Article

References (29)

1. de Martino M, Tovo PA, Balducci M, et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA. 2000;284:190-197.
2. van Rossum AM, Fraaij PL, de Groot R. Efficacy of highly active antiretroviral therapy in HIV-1 infected children. Lancet Infect Dis. 2002;2:93-102.
3. McComsey G, Bhumbra N, Ma JF, Rathore M, Alvarez A. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study. Pediatrics. 2003;111:e275-e281.
4. Carr A, Emery S, Law M, Puls R, Lundgren JD, Powderly WG. An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet. 2003;361:726-735.
5. Brambilla P, Bricalli D, Sala N, et al. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy. AIDS. 2001;15:2415-2422.
6. Hui DY. Effects of HIV protease inhibitor therapy on lipid metabolism. Prog Lipid Res. 2003;42:81-92.
7. Bodasing N, Fox R. HIV-associated lipodystrophy syndrome: description and pathogenesis. J Infect. 2003;46:149-154.
8. Wedekind CA, Pugatch D. Lipodystrophy syndrome in children infected with human immunodeficiency virus. Pharmacotherapy. 2001;21:861-866.
9. Leonard EG, McComsey GA. Metabolic complications of antiretroviral therapy in children. Pediatr Infect Dis J. 2003;22:77-84.
10. Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet. 1999;353:2093-2099.
11. Saves M, Raffi F, Capeau J, et al. Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis. 2002;34:1396-1405.
12. Sattler F. Body habitus changes related to lipodystrophy. Clin Infect Dis. 2003;36:884-890.
13. Amaya RA, Kozinetz CA, McMeans A, Schwarzwald H, Kline MW. Lipodystrophy syndrome in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2002;21:405-410.
14. Cossarizza A, Mussini C, Vigano A. Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders? Bioessays. 2001;23:1070-1080.
15. Grunfeld C. Overview of FRAM.
16. Grunfeld C, Tien P. Difficulties in understanding the metabolic complications of acquired immune deficiency syndrome. Clin Infect Dis. 2003;37:S43-S46.
17. Carr A, Miller J, Law M, Cooper DA. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS. 2000;14:F25-F32.
18. Moyle G. Lipodystrophy: lack of agreement on definition and etiology presents a challenge to research and therapy. AIDS Read. 2002;12:438, 440-402.
19. Safrin S, Grunfeld C. Fat distribution and metabolic changes in patients with HIV infection. AIDS. 1999;13:2493-2505.
20. Centers for Disease Control and Prevention. 1994 revised classification system for human immunodeficiency infection in children less than 13 years of age. MMWR. 1994;43:1-19.
21. Gerver W, de Bruin R. Paediatric morphometrics: a reference manual. 2nd ed. >Maastricht: Universitaire Pers Maastricht; 2001.
22. Shearer WT, Rosenblatt HM, Gelman RS, et al. Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. J Allergy Clin Immunol. 2003;112:973-980.
23. Fredriks A, van Buuren S, Burgmeijer R, Verloove-Vanhorick S, Wit J. Groeidiagrammen: Handleiding bij het meten en wegen van kinderen en het invullen van groeidiagrammen. 2nd ed. Leiden, the Netherlands: TNO/LUMC: 2002.
24. Fredriks AM, van Buuren S, Fekkes M, Verloove-Vanhorick SP, Wit JM. Are age references for waist circumference, hip circumference and waist-hip ratio in Dutch children useful in clinical practice? Eur J Pediatr. 2005;164:216-222.
25. Comans-Bitter WM, de Groot R, van den Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388-393.
26. Jaquet D, Levine M, Ortega-Rodriguez E, et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS. 2000;14:2123-2128.
27. Babl FE, Regan AM, Pelton SI. Abnormal body-fat distribution in HIV-1-infected children on antiretrovirals. Lancet. 1999;353:1243-1244.
28. Beregszaszi M, Jaquet D, Levine M, et al. Severe insulin resistance contrasting with mild anthropometric changes in the adipose tissue of HIV-infected children with lipohypertrophy. Int J Obes Relat Metab Disord. 2003;27:25-30.
29. Malina RM, Huang YC, Brown KH. Subcutaneous adipose tissue distribution in adolescent girls of four ethnic groups. Int J Obes Relat Metab Disord. 1995;19:793-797.